Prelude Therapeutics
Earnings Surprise
Analysts estimated PRLD earnings of $-0.03 per share this quarter (Q4). PRLD's actual earnings were $-0.20 per share.
PRLD EPS surprise of -575.68%Analysts estimated PRLD earnings of $-0.37 per share this quarter (Q3). PRLD's actual earnings were $-0.26 per share.
PRLD EPS surprise of 30.22%Analysts estimated PRLD earnings of $-0.45 per share this quarter (Q2). PRLD's actual earnings were $-0.41 per share.
PRLD EPS surprise of 8.54%Analysts estimated PRLD earnings of $-0.48 per share this quarter (Q1). PRLD's actual earnings were $-0.42 per share.
PRLD EPS surprise of 12.08%Analysts estimated PRLD earnings of $-0.47 per share this quarter (Q4). PRLD's actual earnings were $-0.38 per share.
PRLD EPS surprise of 19.59%Analysts estimated PRLD earnings of $-0.48 per share this quarter (Q3). PRLD's actual earnings were $-0.43 per share.
PRLD EPS surprise of 10.64%Analysts estimated PRLD earnings of $-0.49 per share this quarter (Q1). PRLD's actual earnings were $-0.42 per share.
PRLD EPS surprise of 15.10%Analysts estimated PRLD earnings of $-0.50 per share this quarter (Q2). PRLD's actual earnings were $-0.42 per share.
PRLD EPS surprise of -16.82%Analysts estimated PRLD earnings of $-0.50 per share this quarter (Q4). PRLD's actual earnings were $-0.46 per share.
PRLD EPS surprise of -7.96%